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Abstract
Objective
During the ongoing global pandemic of novel coronavirus disease 2019 (COVID-19), an emerging infectious
disease, the implementation and execution of infection prevention and control (IPC) is of paramount
importance. In this study, we aimed to assess the current deployment of infection control medical personnel
in Okayama prefecture, who are supposed to play an essential role to prevent the outbreak of infectious
diseases, and the current prevalence of antimicrobial-resistant (AMR) bacteria isolated in Okayama.
Materials and methods
This was a descriptive study using publicly available data. The numbers of infectious disease (ID)-doctors
and the certified nurses in infection control (CNIC) per 100,000 population in 47 prefectures in Japan were
calculated. We then compared the detected proportions of AMR pathogens among the prefectures in 2019 to
be employed as a comparative parameter, which was obtained from Japan Nosocomial Infections
Surveillance (JANIS) data.
Results
The number of ID-doctors was the 11th  highest in Japan; however, they were unevenly distributed in
southern Okayama, particularly at three tertiary hospitals. While the deployment of CNIC
was geographically less uneven in the prefecture, their number was lower than the domestic average.
According to the JANIS data, isolation rates of AMR pathogens were high in Okayama compared to other
prefectures in Japan: vancomycin-resistant Enterococcus faecium (the third-worst); cefotaxime-resistant
Escherichia coli and Klebsiella pneumoniae (the third-worst and the second-worst, respectively); and
meropenem-resistant Pseudomonas aeruginosa (the worst).
Conclusions
Our assessment provides underlying data and reinforces the need for educating multi-professional experts in
the field of infectious diseases to prevent future public health threats in Okayama.
Categories: Medical Education, Infectious Disease, Epidemiology/Public Health
Keywords: antimicrobial resistance, certified nurses in infection control, infection prevention and control, infectious
disease doctors, japan nosocomial infections surveillance
Introduction
The current global pandemic of novel coronavirus disease 2019 (COVID-19) has strongly raised social
awareness concerning the importance of infection prevention and control (IPC) in medical institutions and
communities [1]. In response to the unprecedented pandemic, we progressively need to devise a framework
for the IPC system based on multidisciplinary perspectives, such as medical, epidemiological, administrative,
financial, legal, and economic views. It is especially essential to boost both the quality and quantity of
preventive measures at medical facilities so that we can prevent nosocomial infections and provide safe
healthcare to the public.
In this vertically-segmented medical specialist system, infectious disease (ID)-doctors and the certified
nurses in infection control (CNIC) are expected to play an active role in implementing IPC activities at each
medical institution. As of October 1, 2020, the number of Board Certified Physicians of the Japanese
Association for Infectious Diseases was 1,554 in Japan [2]. A total of 2,852 registered nurses had been
certified as CNIC by the Japanese Nursing Association [3]. According to a statement issued by the Japanese
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Association for Infectious Diseases, each medical institution with over 300 beds should have at least one
full-time ID-doctor on duty [4]. For CNIC, the Centers for Disease Control and Prevention of the United
States mandates that medical facilities should have one CNIC per 250 hospital beds [5]. As for IPC services in
clinical settings, it is not realistic to uniformly deploy or centralize the expertise by establishing a specific
infectious disease center, because the infectious diseases are diverse and numerous, and usually develop
acutely and require a rapid response. Hence, it is now generally accepted that medical facilities of a certain
size should have ID-doctors and CNIC on-site in full-time positions to develop highly effective IPC
activities.
In this study, we aimed to determine the current deployment status of ID-doctors and CNIC in Okayama
prefecture based on quantitative and geographical perspectives, in comparison to the rest of Japan.
Additionally, we assessed the recent prevalence of antimicrobial-resistant (AMR) bacteria isolated in
Okayama by searching the national open data provided by the Japanese Ministry of Health, Labor, and
Welfare. Our main goal is to provide fundamental data to educate multi-professional experts in the field of
infectious diseases in Okayama.
Materials And Methods
This was a descriptive study that used publicly available data. Population data were collected from the
website of the Statistics Bureau of the Ministry of Internal Affairs and Communications [6]. We defined ID-
doctors as those who are registered as Board Certified Physicians of the Japanese Association for Infectious
Diseases. Data on the number of ID-doctors at each prefecture, as of October 1, 2020, was obtained from the
Japanese Association for Infectious Diseases [2]. Additionally, we defined CNIC accredited by the Japanese
Nursing Association as those who are employed as infection control nurses at medical facilities [3]. We
calculated the numbers of ID-doctors and CNIC per 100,000 population in each prefecture and comparisons
were performed among the prefectures. To understand the geographical distribution of ID-doctors and CNIC
in Okayama prefecture, we divided the Okayama prefecture into three distinct regions: (i) a south-eastern
region around Okayama city, (ii) a south-western region around Kurashiki city, and (iii) a northern region
around Tsuyama city.
To evaluate the effectiveness of IPC activities in Okayama, we compared the detected proportions of AMR
pathogens among the prefectures to be employed as a comparative parameter. Data on the isolation rates of
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin (VCM)-resistant Enterococcus faecium
(VRE), third-generation cephalosporin [cefotaxime (CTX)]-resistant Escherichia coli (E. coli) and Klebsiella
pneumoniae (K. pneumoniae), fluoroquinolone [levofloxacin (LVFX)]-resistant E. coli and K. pneumoniae, and
carbapenem [meropenem (MEPM)]-resistant Pseudomonas aeruginosa (P. aeruginosa) were collected from
Japan Nosocomial Infections Surveillance (JANIS) data, which was open to the public [7]. The JANIS service
was launched in 2000 as a sustainable surveillance model for national AMR data with the support of the
Japanese government, which has been developed into one of the largest national AMR surveillance
worldwide [8,9]. MRSA is generally defined as an S. aureus strain showing resistance to either oxacillin or
cefoxitin (CFX); however, in this study, no corresponding data were available in the JANIS public
information system, and hence we considered CFX-resistant S. aureus strain as MRSA for the purpose of this
study.
No statistical analysis was performed in this study. Ethics committee approval and the need for informed
consent were waived off by the Institutional Review Board of the Okayama University Hospital since the
detailed data on individuals and hospitals were all anonymized (No. 2103-042).
Results
The number of ID-doctors in Okayama was 27, which amounts to 1.42/100,000 population and is the 11th
highest in Japan (the domestic average is 1.22/100,000 population) (Figure 1A). The number of CNIC in
Okayama was 35 (corresponding to 1.84/100,000 population), which was lower than the domestic average of
2.26/100,000 population (Figure 1B).
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FIGURE 1: The number of ID-doctors (A) and CNIC (B) per 100,000
population by prefectures and the national average in Japan
ID: infectious diseases; CNIC: certified nurse in infection control
Geographical deployment of ID-doctors and CNIC in the Okayama
prefecture
We have presented the number of ID-doctors and CNIC per 100,000 population in three distinct regions of
Okayama prefectures along with the domestic average (Figure 2). Out of 27 ID-doctors, we used the
affiliation data of 26 ID-doctors because the data of one doctor was not available. We included the data of 32
CNIC in the investigation by excluding three nurses (one did not belong to a medical institution and the
affiliation data of two were unknown). In the south-eastern region, there were 10 ID-doctors in Okayama
city (but not in the other cities) and 20 CNIC (16 in Okayama city, three in Setouchi city, and one in Kibi
Chuo town). The population ratios of ID-doctors (1.08/100,000 population) and CNIC (2.28/100,000
population) were nearly equal to the domestic averages. In the south-western region, there were 15 ID-
doctors (13 in Kurashiki city, one in Kasaoka city, and one in Hayashima town) and nine CNIC (seven in
Kurashiki city, one in Ibara city, and one in Hayashima town). The population ratio of ID-doctors
(2.12/100,000 population) was well above the domestic average (1.23/100,000 population), while that of
CNIC in the region (1.27/100,000 population) was below the domestic average (2.26/100,000 population). In
the northern region, there was one ID-doctor (Mimasaka city) and three CNIC (two in Tsuyama city and one
in Maniwa city). The population ratios of ID-doctors (0.34/100,000 population) and CNIC (1.03/100,000
population) were much below the domestic averages. Deployment of ID-doctors in the south-eastern and
south-western regions seems sufficient; however, when studied in detail, we found that their
affiliations/distribution were uneven, and they were mostly found affiliated to two university hospitals
(seven at Kawasaki Medical School Hospital and four at Okayama University Hospital) and a tertiary hospital
(four at Kurashiki Central Hospital). In contrast, we found that CNIC was almost evenly distributed in the
major medical institutions in each region.
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FIGURE 2: The number of ID-doctors and CNIC per 100,000 population
in three distinct regions of the Okayama prefecture and the national
average
ID: infectious diseases; CNIC: certified nurse in infection control
Recent epidemiological data on AMR bacteria in Okayama in
comparison with other prefectures
The number of medical institutions in Okayama that provided microbiology data to JANIS in the fiscal year
2019 was 50 in total; two of them had more than 900 beds, four had 500-899 beds, 13 had 200-499 beds, and
31 had less than 200 beds. This corresponded to 30.7% of medical institutions registered in the prefecture.
Isolation rates of MRSA were 56.6% (the 9th most prevalent) (Figure 3A). VCM susceptibility rates of E.
faecium were 95.0% (the 3rd lowest), i.e., isolation rates of VRE in E. faecium were 5.0% (Figure 3B). CTX-
and LVFX-susceptibility rates of E. coli were 61.9% (the 3rd lowest) and 50.1% (the 5th lowest), respectively
(Figure 4). Similarly, CTX- and LVFX-susceptibility rates of K. pneumoniae were 83.3% (the 2nd lowest) and
90.7% (the 2nd lowest), respectively (Figure 5). Finally, MEPM-susceptibility rates of P. aeruginosa were
79.1% (the lowest) (Figure 6).
FIGURE 3: The proportion of MRSA to the total isolation of S. aureus (A)
and antimicrobial susceptibility of VCM for E. faecium (B) in each
prefecture of Japan in 2019
The detection rate of the AMR bacteria increases from the right to the left. The proportion of MRSA was
estimated by cefoxitin susceptibility testing
MRSA: methicillin-resistant Staphylococcus aureus; S. aureus: Staphylococcus aureus; VCM: vancomycin; E.
faecium: Enterococcus faecium; AMR: antimicrobial-resistant
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FIGURE 4: Antimicrobial susceptibility rates of CTX (A) and LVFX (B) for
E. coli in each prefecture of Japan in 2019
The detection rate of the AMR bacteria increases from the right to the left
CTX: cefotaxime; LVFX: levofloxacin; E. coli: Escherichia coli; AMR: antimicrobial-resistant
FIGURE 5: Antimicrobial susceptibility rates of CTX (A) and LVFX (B) for
K. pneumoniae in each prefecture of Japan in 2019
The detection rate of the AMR bacteria increases from the right to the left
CTX: cefotaxime; LVFX: levofloxacin; K. pneumoniae: Klebsiella pneumoniae; AMR: antimicrobial-resistant
2021 Hagiya et al. Cureus 13(7): e16643. DOI 10.7759/cureus.16643 5 of 8
FIGURE 6: Antimicrobial susceptibility rates of meropenem for P.
aeruginosa in each prefecture of Japan in 2019
The detection rate of the AMR bacteria increases from the right to the left
P. aeruginosa: Pseudomonas aeruginosa; AMR: antimicrobial-resistant
Discussion
In this study, we evaluated the current deployment status of infectious diseases experts in Okayama
prefecture based on publicly available data and compared it with that of other prefectures. Briefly, although
the number of ID-doctors in Okayama was the 11th highest among the prefectures in Japan, they were
unevenly distributed and a higher number of ID-doctors were present in the southern regions, particularly at
three tertiary hospitals. There were no ID-doctors at a few of the key regional hospitals. In the northern
region, ID-doctors were underrepresented in terms of numbers. In contrast, in the case of CNIC, there was a
less geographically biased distribution; however, the registered number in Okayama was comparatively
small. Notably, based on the JANIS data, the isolation rates of AMR pathogens in Okayama were high in the
year 2019. MRSA, VRE, and CTX- and LVFX-resistant E. coli and K. pneumoniae, and carbapenem-resistant P.
aeruginosa are all representative nosocomial pathogens that should be brought under control by strict IPC
activities. Because of its sophisticated system and well-established database, the JANIS data is reported to
be a powerful surveillance tool for the regional prevalence of AMR pathogens [10] and has the potential to be
further applied for automated AMR detection systems by using a cluster detection software tool, called
SaTScan [11]. Thus, JANIS data is useful to understand the trends in the detection of AMR pathogens. High
detection rates of the representative AMR organisms may suggest a relative inadequacy of IPC measures in
Okayama, which might be, at least partially, a consequence of the shortage and unequal distribution of the
infectious diseases expertise.
Although the number of ID-doctors appears to be sufficient, their skewed distribution in the prefecture
limits the promotion of IPC activities across the prefecture. Besides, the ID-doctors would have diverse
clinical backgrounds and subspecialties, and thus, their knowledge and experiences in IPC greatly differ
from each other. It is also true that non-ID-doctors are responsible for the IPC activities at each facility and
function effectively. Thus, it would be not enough to evaluate the activity level of IPC in the whole
prefecture solely based on the distribution of ID-doctors, which could be one of the limitations of this study.
Other qualifications that potentially cover the ability of IPC for physicians include the Infection Control
Doctor (ICD) system, Certified Board of Pediatric Infectious Diseases (accredited by the Japanese Society for
Pediatric Infectious Diseases), Fellow of Japanese Antimicrobial Chemotherapy Physician (accredited by the
Japanese Society of Chemotherapy), and Certified Fellow of the Japanese Society for Clinical Microbiology.
However, none of them can assure the doctor's ability to contribute to the IPC. As of January 2019, the
number of ICD holders reached 9,362 in the whole country, but no data by prefectures are open to the public
and, hence, we are skeptical as to the number of individuals among these ICDs who have actually
contributed to the IPC activity at their institutions.
In contrast with ID-doctors, there was no geographic imbalance in CNIC deployment, although the number
of CNIC was comparatively less. A plausible reason for the absence of uneven distribution in CNIC could be
that a full-time CNIC on duty is a requirement for obtaining additional reimbursement for infection
prevention. In other words, the education and employment of CNIC can directly increase the revenue for
healthcare facilities. Another limitation of this study is that it is unclear whether CNIC certificate holders
work full-time in such positions at their respective medical institutions. That is, although the registered
number of CNIC certificate holders appears to be sufficient, some of them may not necessarily be working as
CNIC. Similar to medical doctors, there are other career paths or certifications other than CNIC in the
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nursing profession, and the assessment for CNIC alone may be insufficient to estimate the current
sufficiency of nurses involved in IPC activities in Okayama. To get certified as CNIC, a nurse has to join a
half-year training course and spend several million Japanese yen at personal capacity. The time and
economic constraints have surely hindered the efforts to increase the number of CNIC certificate holders. To
further ensure that medical institutions in Okayama are well equipped with CNIC, flexible employment and
financial support for their education would be indispensable.
To evaluate the activity of IPC, antimicrobial stewardship should be a good comparative parameter as well.
In the Japanese National Action Plan on Antimicrobial Resistance launched in 2016 [12], compared to 2013,
it was proposed that the use of antimicrobials in 2020 should be reduced by 33% in total: 50% for oral
cephalosporins, fluoroquinolones, and macrolides, and 20% for intravenous drugs. Based on the National
Database of Health Insurance Claims and Specific Health Checkups of Japan, calculated based on the data
from AMR Clinical Reference Center [13], as of 2019, the use of intravenous agents increased by 3.9% across
the country. However, the oral antimicrobial use of cephalosporins, quinolones, and macrolides favorably
decreased by 14.2%, 9.7%, and 12.7%, respectively, although the goals were not achieved till 2020. In
addition, according to the AWaRe classification proposed by the World Health Organization (WHO), a
proportion of Access group antimicrobials is on an increasing trend (18.1%, as of 2019), while that of Watch
group antimicrobials has decreased to 80.1%, suggesting that the antimicrobial use is gradually being
optimized in Japan [14]. However, the data from AMR Clinical Reference Center revealed that the defined
daily dose of intravenous/oral and oral antimicrobial uses in Okayama was 14.95 (the 11th highest in the
country) and 13.93 (the 12th highest in the country), respectively [15]. This data indicates the need to further
promote antimicrobial stewardship in Okayama, besides IPC activities. From a long-term perspective, in
addition to continuous education to medical doctors, it is also fundamental to use the bottom-up approach
to increase awareness and knowledge of the proper use of antimicrobials in pre- and post-graduate
educational systems.
Not only the medical doctors and nurses, but also other medical practitioners such as pharmacists, clinical
laboratory technicians, and even clerical staff could play an important role in IPC activities. For example,
pharmacists should be closely involved in antimicrobial stewardship, or the appropriate use of antimicrobial
drugs. Clinical laboratory technicians should make a significant contribution to the rapid detection and data
management of AMR bacteria. Professional qualifications systems for the medical personnel, namely,
infectious disease chemotherapy pharmacist (IDCP) and board-certified infection control pharmacy
specialist (BCIPS) for pharmacists, and infection control microbiological technologist (ICMT) for clinical
laboratory technicians, have already been established. Professional education in these fields could further
facilitate the IPC activities in a hospital.
Conclusions
Our analysis revealed the uneven distribution of ID-doctors and a shortage of CNIC in Okayama, despite the
high isolation rates of AMR pathogens. Although the causal relationship between these data is unclear, we
should progressively work on improving the current situation. First of all, from a long-term perspective,
medical schools need to include clinical infectious diseases in the pre-graduate education curriculum.
Additionally, as a subject of intensive post-graduate education, infectious diseases should be more
frequently and regularly addressed, which could help in the increase of ID expertise in the future. Currently,
we need to establish a comprehensive system for regional cooperation with neighboring healthcare
institutions in improving the level of IPC in the entire region. This is the right time to promote a continuous
education system concerning infectious diseases to achieve sustainable development goals in terms of
infection control and prevention in Okayama.
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